Elliot Israel MD

Pulmonology•Brookline, MA

Asthma & COPD, Critical Care Medicine, Pleural Disease

Professor of Medicine, Harvard Medical School, Brigham and Women's Hospital

Join to View Full Profile

111 Cypress StBrookline, MA 02445
Phone+1 857-307-0896

Education & Training

Mass General Brigham/Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1985
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1981 - 1982
Johns Hopkins UniversityResidency, Internal Medicine, 1979 - 1981
Johns Hopkins University School of MedicineClass of 1979

Certifications & Licensure

FL State Medical License 2021 - 2026
MA State Medical License 1982 - 2025
NH State Medical License 2021 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology

Clinical Trials

Asthma Clinical Research Network (ACRN) Start of enrollment: 1993 Sep 01
Withdrawn
Phase 3
Predicting the Response to Montelukast by Genetic Variation in Asthmatics Start of enrollment: 2003 Apr 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Long-Acting Beta Agonist Response by Genotype (LARGE) Start of enrollment: 2004 Dec 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Macrolides in Asthma (MIA) Start of enrollment: 2006 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Best Adjustment Strategy for Asthma in Long Term (BASALT) Start of enrollment: 2007 Jun 01
Completed
Phase 3
Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC) Start of enrollment: 2008 May 01
Completed
Phase 3
How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment Start of enrollment: 2008 Jan 01
Completed
Not Applicable
The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations Start of enrollment: 2008 Jun 01
Terminated
Not Applicable
Effects of cKit Inhibition by Imatinib in Patients With Severe Refractory Asthma (KIA) Start of enrollment: 2010 Nov 01
Completed
Phase 2
Study of the Effect of Vitamin D as an Add-on Therapy to Corticosteroids in Asthma Start of enrollment: 2011 Apr 01
Completed
Phase 3
Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT) Start of enrollment: 2011 Mar 30
Completed
Phase 3
Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment Start of enrollment: 2012 Oct 01
Completed
Not Applicable
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease (Aspirin) Start of enrollment: 2012 Aug 31
Completed
Phase 2
Severe Asthma Research Program
ACTIVE_NOT_RECRUITING
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma Start of enrollment: 2013 Mar 01
Completed
Phase 2
The Severe Asthma Research Program III-Boston Clinical Site Start of enrollment: 2012 Dec 01
Completed
Fatty Acids in Airway Smooth Muscle of Asthmatics
WITHDRAWN
NA
Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief Start of enrollment: 2017 Nov 27
Completed
Phase 4
Therapeutic Control of Aspirin-Exacerbated Respiratory Disease With Ifetroban Start of enrollment: 2018 Apr 26
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma.
Clarus Leung, Monica Tang, Walter E Finkbeiner, Mats W Johansson, Loren C Denlinger
American Journal of Respiratory and Critical Care Medicine. 2025-02-25
1 citations
α1-Antitrypsin Gene Variation Associates with Asthma Exacerbations and Related Health Care Utilization.
Victor E Ortega, Vickram Tejwani, Abhishek Kumar Shrivastav, Sara Pasha, Joe G Zein
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-13
2 citations
Type 1 Immune Responses Related to Viral Infection Influence Corticosteroid Response in Asthma.
John V Fahy, Nathan D Jackson, Satria P Sajuthi, Elmar Pruesse, Camille M Moore
American Journal of Respiratory and Critical Care Medicine. 2025-02-01

Other

Aspirin exacerbated respiratory disease
Israel E
http://www.uptodate.com/contents/aspirin-exacerbated-respiratory-disease
UpToDate, Wolters Kluwer Health - 2012-12-18

Authored Content

AAAAI 2022: As-Needed Inhaled Corticosteroid Improves Asthma Outcomes in Black and Latinx Adults with AsthmaMarch 2022

Press Mentions

National Asthma Study Points to Better Outcomes for Black and Latinx PatientsMay 20th, 2022
A New Approach to Severe Asthma Could Reduce Racial Health Disparities, Researchers SayMarch 15th, 2022
Strategy for Inhaled Corticosteroid Use Leads to Better Asthma Outcomes, According to National Study of Black and Latinx PatientsMarch 8th, 2022
Join now to see all

Grant Support

Immunometabolic phenotypes in adult severe asthma and disease progressionBRIGHAM AND WOMEN'S HOSPITAL2019–2025
Immunometabolic phenotypes in adult severe asthma and disease progressionBRIGHAM AND WOMEN'S HOSPITAL2019–2025